Christopher Anderson MD, MS
Massachusetts General Hospital
Dr. Christopher Anderson is a Neurocritical Care and Acute Stroke physician with research expertise in the medical genetics of complex disease, specifically ischemic and hemorrhagic stroke. He has devoted his research career to leveraging computational, genetic, and epidemiologic tools to define mechanisms underlying cerebrovascular disease, with the ultimate goal of using this information to drive improvement in stroke care through the identification of novel treatment targets and implementation of precision strategies for primary and secondary prevention. He is clinically appointed at Massachusetts General Hospital in the Division of Neurocritical Care and Emergency Neurology where he is Director of Acute Stroke Services. He also has research faculty appointments at the MGH Center for Genomic Medicine and the Broad Institute of MIT and Harvard. He holds a K23 and R01 from the NINDS, a Catalysis Award from the MGH Center for Genomic Medicine, and is a co-PI of the Boston University/MGH site of the American Heart Association Strategically Focused Research Network for Atrial Fibrillation.